Correlations of acute myocardial infarction complicated by cerebral infarction with insulin resistance, adiponectin and HMGB1.

  title={Correlations of acute myocardial infarction complicated by cerebral infarction with insulin resistance, adiponectin and HMGB1.},
  author={J. Chen and W. Zhang and Y-Q Wu and H. Chen and J-F Zhao},
  journal={European review for medical and pharmacological sciences},
  volume={23 10},
  • J. Chen, W. Zhang, +2 authors J-F Zhao
  • Published 2019
  • Medicine
  • European review for medical and pharmacological sciences
OBJECTIVE To investigate the correlations of acute myocardial infarction (AMI) complicated by cerebral infarction with insulin resistance, adiponectin and high-mobility group box 1 (HMGB1). PATIENTS AND METHODS A total of 326 AMI patients receiving percutaneous coronary intervention (PCI) were selected as the research objects. They were divided into cerebral infarction group (n=24) and non-cerebral infarction group (n=302) based on their complication of cerebral infarction. In addition, 165… Expand
Influences of a hierarchical nursing model on rescue outcomes and nursing quality of patients with acute cerebral infarction.
  • Xuemei An, Longying Zeng, Liping Shen, Yunlan Jiang
  • Medicine
  • American journal of translational research
  • 2021
Hierarchical nursing can remarkably shorten the rescue time, improve the success rate of rescue, neurological function and quality of life of patients with ACI, improve nursing quality of nursing staff, and reduce the incidence rate of adverse reactions. Expand


The clinical value of circulating miR-99a in plasma of patients with acute myocardial infarction.
The expression level of plasma miR-99a was remarkably reduced following AMI and closely associated with the severity of AMI, and was a promising novel diagnostic biomarker for AMI. Expand
The mechanism of exogenous adiponectin in the prevention of no-reflow phenomenon in type 2 diabetic patients with acute myocardial infarction during PCI treatment.
Exogenous adiponectin further reduced the no-reflow phenomenon during PCI treatment of the patients with T2DM combined with AMI and is associated with the reduced myocardial and endothelial cell injury and the inhibited inflammation and apoptosis. Expand
Salivary and serum adiponectin and C‐reactive protein levels in acute myocardial infarction related to body mass index and oral health
These initial data provide evidence relating obesity and oral health to salivary and serum analyte levels that occur in association with cardiac events, and indicated that oral health and obesity contribute to altering levels of these salivaries and serum analyzetes in associationWith cardiac events. Expand
Effects of recombinant human brain natriuretic peptide on the prognosis of patients with acute anterior myocardial infarction undergoing primary percutaneous coronary intervention: a prospective, multi-center, randomized clinical trial.
Early intravenous rhBNP administration after PCI significantly lowered the serum concentrations of cTnT and NT-proBNP, increased LVEDd, SV and LVEF, and reduced MACEs, including cardiac death, in patients with acute anterior MI undergoing PCI. Expand
Efficacy and safety of pitavastatins in patients with acute myocardial infarction: Livalo in Acute Myocardial Infarction Study (LAMIS) II
Although LDL-C was reduced more significantly by using 4 mg of pitavastatin compared to 2mg of pitvastatin, the event rate was comparable without adverse effects on glucose tolerance in both groups in AMI patients who were enrolled in LAMIS-II. Expand
Clinical Value of Combined Detection of CK-MB, MYO, cTnI and Plasma NT-proBNP in Diagnosis of Acute Myocardial Infarction.
It is suggested that detecting CK-MB, MYO, cTnI, and plasma NT-proBNP levels together can significantly contribute to the early diagnosis of AMI and provide diagnostic evidence to clinic and thus lower the mortality of AMi in acute phase. Expand
Admission serum potassium concentration and long-term mortality in patients with acute myocardial infarction: results from the MONICA/KORA myocardial infarction registry
An admission SPC of ≥5.0 mEq/l might be associated with an increased mortality risk in patients with AMI, and an increase in the first few years following AMI in patients recruited from a population-based registry is examined. Expand
Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction.
The hypothesis that individual differences in the intensity of the post-AMI inflammatory response, involving 1 or more inflammatory-modulating pathways, may contribute to adverse LV remodeling is reviewed, outlining how individual variations in the inflammatory response could provide important novel therapeutic targets and strategies. Expand
Prognostic impact of spontaneous coronary artery dissection in young female patients with acute myocardial infarction: A report from the Angina Pectoris-Myocardial Infarction Multicenter Investigators in Japan.
Young female patients with SCAD represent a high-risk subgroup of patients with AMI and require close follow-up, and Kaplan-Meier analysis showed a significantly higher incidence of MACE in the SCAD group compared to the no-SCAD group. Expand
C1q/Tumor Necrosis Factor-Related Protein 9 Protects against Acute Myocardial Injury through an Adiponectin Receptor I-AMPK-Dependent Mechanism
CTP9 protects against acute cardiac damage in response to pathological stimuli by suppressing inflammatory reactions through AdipoR1/AMPK-dependent mechanisms. Expand